Sign inJoin waitlistJoin the waitlist

AK

Atif Khan

Chief, External Beam Radiotherapy: MSK Basking Ridge and MSK Monmouth · New York Presbyterian Hospital

Credentials: · · · · ·

History

External Beam Radiotherapy: MSK Basking Ridge and MSK Monmouth Division · New York Presbyterian Hospital
Present

Dana-Farber Cancer Institute
2005–2006
Fellowship Brigham and Women's Hospital
2004–2005
Radiation Oncology
Rush University Medical Center
2000–2004
Preliminary or Transitional Year
1999–2000
Radiological Sciences, Rush University - The Graduate College
Aga Khan Med Coll, Karachi, Pakistan
1995–1999

Research

Non-cell-autonomous cancer progression from chromosomal instability
Nature · 2023 · 278 citations
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status
The Lancet · 2002 · 207 citations
Adenoid cystic carcinoma: a retrospective clinical review
Review · International Journal of Cancer · 2001 · First of 7 authors · 204 citations

LB
Lior Braunstein
51 papers
Simon Powell
51 papers
Bruce Haffty
50 papers
FV
Frank Vicini
41 papers
Sharad Goyal
31 papers · 1 as a resident
BM
Beryl McCormick
30 papers
Chirag Shah
30 papers · 1 as a resident
Oren Cahlon
29 papers
Erin Gillespie
27 papers
BM
Boris Mueller
24 papers
DA
Douglas Arthur
22 papers
JC
John Cuaron
19 papers

Clinical trials

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Principal investigator · Recruiting
Memorial Sloan Kettering Cancer Center
2023–2027
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2021–2027
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2019–2027
A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2018–2025